GoingToMeet

The conference has been designed as an interesting blend of regulatory, chemical, biological and clinical science to be suitable for delegates wanting to gain a broad multi-disciplinary understanding of how to get a suitable candidate drug substance approved for clinical trials and for later sale and supply as a licensed medicine (drug product) in the European Union (EU). Delegates will see and better understand how to navigate EU pharmaceutical legislation impacting on clinical trials, licensing and post-licensing phases in the life cycle of modern medicines. They will also learn many of the important scientific and technical issues on which pharmaceutical, non-clinical and clinical assessors must be reassured before approvals will be given.

The learning experiences will be delivered by expert speakers with international experience and reputation. Six of the expert panel currently work or have worked within various regulatory authorities. The lectures will be supported by Mini-Workshops wherein delegates will discuss within groups various questions pertinent to the training programme; delegates' feedback will be supported by views from the panel of speakers.